Go back to the main page.
Transforming Today's Science Into Tomorrow's Cures
Samaritan's collaborative researchers have made important patented discoveries in the fields of, central nervous system diseases, such as, Alzheimer's disease; cancer; cardiovascular disease; and infectious diseases, such as, AIDS, and Hepatitis C. These discoveries have positioned us with a rich pipeline of new drugs with novel mechanisms of actions to develop.
Samaritan Pharmaceuticals, Inc. is an entrepreneurial biopharmaceutical company focused on the development and marketing of innovative therapeutics. At Samaritan Pharmaceuticals our mission has been to create life-saving drugs for people suffering from AIDS, Alzheimer’s, heart disease and cancer. View all the latest press releases and news articles focused on Samaritan Pharmaceuticals, Inc. These publications, called peer-reviewed journals, are scholarly periodicals requiring each article submitted be judged by an independent panel of experts (scientific peers) to authenticate the accuracy of the material. The number of articles printed and the variety of publications accepting the article serve to underscore the legitimacy of information. Samaritan has collaborative relationships with other pharmaceutical companies to commercialize branded approved prescription products in selected niche territories, such as, in Greece, Albania, Bosnia, Bulgaria, Croatia, Cyprus, Czech Republic, Egypt, FYROM, Hungary, Montenegro, Poland, Romania, Serbia, Slovakia, Slovania, Syria and Turkey. Before a drug can be offered to the public it must go through several phases of rigorous testing to make sure it is safe, efficient and does what it says it can do. The testing is mandated and overseen by the U.S. Food and Drug Administration (FDA) which is part of the U.S. Department of Health and Human Services. SAMARITAN PIPELINE - (MECHANISM OF ACTION VIDEOS)
Go back to the main page. Contact Samaritan Pharmaceuticals, Inc. Find what you are looking for in our website.
CURRENT NEWS AND PR
2008
Samaritan Therapeutics Signs Research Collaboration and Licensing Agreement With The Research Institute of McGill University Health CentreNEWS - February 13, 2008
Samaritan Therapeutics Names Entrepreneurial MD President
 
Samaritan to Host 2007 Annual Meeting October 23, 2007NEWS - February 05, 2008
Samaritan Sales Revenue Growing
 
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent OfficeNEWS - February 01, 2008
SP-01A Provides HIV Patients Improved Quality of Life 
 
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent OfficeNEWS - January 24, 2008
Huntington Disease Foundation to Assess Six of Samaritan's Drugs for Potential to Delay or Slow Progression of the Disease 
 
Samaritan Announces Positive Preliminary Results in a Phase IIb Study for Its Novel Oral HIV Entry InhibitorNEWS - January 22, 2008
Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales
 
Samaritan Announces Positive Preliminary Results in a Phase IIb Study for Its Novel Oral HIV Entry InhibitorNEWS - January 17, 2008
Quality of Life, As Important As Life Itself
 
Samaritan to Host 2007 Annual Meeting October 23, 2007NEWS - January 07, 2008
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
 
NEWS AND PR
2007
 
Samaritan to Host 2007 Annual Meeting October 23, 2007NEWS - December 27, 2007
Samaritan Pharmaceuticals Anticipates Continued Growth in 2008
 
Samaritan to Host 2007 Annual Meeting October 23, 2007NEWS - December 17, 2007
Samaritan Pharmaceuticals Begins Trading On OTC Bulletin Board Under Ticker Symbol SPHC
 
Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30NEWS - December 4, 2007
Samaritan Pharma Retains The Investor Relations Group of New York
 
Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30NEWS - November 27, 2007
Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30
 
International Ranking of Universities:McGill Cracks Distinguished DozenNEWS - November 16, 2007
International Ranking of Universities:McGill Cracks Distinguished Dozen
 
Drug May Restore Memory With Alzheimer's DiseaseNEWS - November 13, 2007
Drug May Restore Memory With Alzheimer's Disease
 

NEWS - November 08, 2007
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval
for HIV Drug Amphocil in Cyprus

 

Actors Studio's Anna Strassberg Joins Samaritan Advisory Board of DirectorsNEWS - November 06, 2007
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
 

Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and CyprusNEWS - October 11, 2007
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
 

Samaritan Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer's Drugs to Partner at Europe's Bio Partnering ConferenceNEWS - October 8, 2007
Samaritan Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer's Drugs to Partner at Europe's Bio Partnering Conference
 

World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory BoardNEWS - October 3, 2007
World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
 

Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor ForumNEWS - October 1, 2007
Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor Forum
 

Samaritan to Host 2007 Annual Meeting October 23, 2007NEWS - September 28, 2007
Samaritan to Host 2007 Annual Meeting October 23, 2007
 

EUSA Pharma Signs Exclusive Distribution Agreement With Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and CyprusNEWS - September 20, 2007
EUSA Pharma Signs Exclusive Distribution Agreement With Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
 

FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II StudyNEWS - September 18, 2007
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
 

The Samaritan Innovative Science Foundation Participating in Macy's Passport In-Store FundraiserNEWS - September 07, 2007
The Samaritan Innovative Science Foundation Participating in Macy's Passport In-Store Fundraiser
 

Audio Interview with Dr. Janet GreesonNEWS - August 28, 2007
Audio Interview with Dr. Janet Greeson
 
Samaritan to Talk Up Its Alzheimer’s, HIV & Stem Cell Drugs on NBC Affiliate KVBC Channel 3NEWS - August 24, 2007
Samaritan to Talk Up Its Alzheimer’s, HIV & Stem Cell Drugs on NBC Affiliate KVBC Channel 3
 
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On ChemotherapyNEWS - August 21, 2007
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy
 
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in PipelineNEWS - August 16, 2007
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
 
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent OfficeNEWS - August 14, 2007
Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent Office  
 
Georgetown University and Samaritan Sign Exclusive Licensing Agreement for Novel Treatment of Cushing's SyndromeNEWS - August 8, 2007
Georgetown University and Samaritan Sign Exclusive Licensing Agreement for Novel Treatment of Cushing's Syndrome
Samaritan's Chief Drug Development Officer to Present Lead Alzheimer's Drug At 12th IBC World CongressNEWS - August 1, 2007
Samaritan's Chief Drug Development Officer to Present Lead Alzheimer's Drug At 12th IBC World Congress 
 
Samaritan Exclusively Licenses Innovative Blood Diagnostic to Uncover Whether Breast Tumor is CancerNEWS - July 30, 2007
Samaritan Exclusively Licenses Innovative Blood Diagnostic to Uncover Whether Breast Tumor is Cancer
 
Samaritan Therapeutics Signs Research Collaboration and Licensing Agreement With The Research Institute of McGill University Health CentreNEWS - July 25, 2007
Samaritan Therapeutics Signs Research Collaboration and Licensing Agreement With The Research Institute of McGill University Health Centre 
 
Samaritan Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown UniversityNEWS - July 24, 2007
Samaritan Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown University 
 
Samaritan Announces Positive Preliminary Results in a Phase IIb Study for Its Novel Oral HIV Entry InhibitorNEWS - July 20, 2007
Samaritan Announces Positive Preliminary Results in a Phase IIb Study for Its Novel Oral HIV Entry Inhibitor
 
Saul Albom interviews Richard Brown, the Investor Relations Specialist for Samaritan Pharmaceuticals.NEWS - July 17, 2007
Saul Albom interviews Richard Brown, the Investor Relations Specialist for Samaritan Pharmaceuticals.
 
VALUERICH Magazine’s Goodwill Hunting Article Identifies Samaritan Foundation’s BioFuture Bus as the “Magic Bus” NEWS - July 17, 2007
VALUERICH Magazine’s Goodwill Hunting Article Identifies Samaritan Foundation’s BioFuture Bus as the “Magic Bus”
 
Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's DiseaseNEWS - July 10, 2007
Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's Disease
 
Nationally Recognized M.D. Joins Samaritan Pharmaceuticals' Board of DirectorsNEWS - June 12, 2007
Nationally Recognized M.D. Joins Samaritan Pharmaceuticals' Board of Directors
 
Samaritan in Collaboration With UCSD Awarded NIH Grant for the Continued Development of Samaritan's Compounds to Suppress HIV Viral Replication and Prevent Neuronal DamageNEWS - June 07, 2007
Samaritan in Collaboration With UCSD Awarded NIH Grant for the Continued Development of Samaritan's Compounds to Suppress HIV Viral Replication and Prevent Neuronal Damage
 
Samaritan Pharma: Early Stage Alzheimer's Disease Diagnostic Patent Issued in AustraliaNEWS - May 29, 2007
Samaritan Pharma: Early Stage Alzheimer's Disease Diagnostic Patent Issued in Australia
 
Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal with Samaritan to Launch REPLAGAL® for Fabry Disease in Greece and CyprusNEWS - May 22, 2007
Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal with Samaritan to Launch REPLAGAL® for Fabry Disease in Greece and Cyprus
 
Samaritan Breast Cancer Diagnostic Issued U.S. PatentNEWS - May 15, 2007
Samaritan Breast Cancer Diagnostic Issued U.S. Patent
 
Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's DrugNEWS - May 3, 2007
Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug
 
Samaritan to Present Novel Alzheimer's Drug Caprospinol (SP-233) at Bio International Convention 2007NEWS - May 1, 2007
Samaritan to Present Novel Alzheimer's Drug Caprospinol (SP-233) at Bio International Convention 2007 
 
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000NEWS - April 10, 2007
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
 
AMEX Panel Grants Samaritan Continued AMEX Listing Pursuant to May 31st Extension to Allow for 10Q Filing...NEWS - April 5, 2007
AMEX Panel Grants Samaritan Continued AMEX Listing Pursuant to May 31st Extension to Allow for 10Q Filing... 
 
Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 MillionNEWS - March 22, 2007
Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million  
 

Good Samaritans Focus on Alzheimer'sMAGAZINE ARTICLE - March 23, 2007
Good Samaritans Focus on Alzheimer's

 

Samaritan In-Licensed AMPHOCIL® Awarded 94 Percent Price Increase With Pricing Approval in GreeceNEWS - March 08, 2007
Samaritan In-Licensed AMPHOCIL® Awarded 94 Percent Price Increase With Pricing Approval in Greece
 

Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug Caprospinol (SP-233)NEWS - March 05, 2007
Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug Caprospinol (SP-233)
 

Audio Interview with Dr. Janet GreesonNEWS - March 01, 2007
Audio Interview with Dr. Janet Greeson
 

Samaritan Pharma Completes Acquisition of Metastatin PharmaceuticalsNEWS - March 01, 2007
Samaritan Pharma Completes Acquisition of Metastatin Pharmaceuticals
 

Shire plc Signs Marketing Agreement With Samaritan PharmaNEWS - February 26, 2007
Samaritan to Distribute Shire Drug in Greece and Cyprus
 

Shire plc Signs Marketing Agreement With Samaritan PharmaNEWS - February 26, 2007
Shire plc Signs Marketing Agreement With Samaritan Pharma
 

Samaritan Pharma Files Patent to Protect SP-04 as Bioterrorism Nerve Gas AntidoteNEWS - February 22, 2007
Samaritan Pharma Files Patent to Protect SP-04 as Bioterrorism Nerve Gas Antidote
 

Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for Cushing's SyndromeNEWS - February 6, 2007
Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for Cushing's Syndrome
 

Samaritan Pharma's SP-10 Hip on Hep C - (Hepatitis C Virus)NEWS - January 25, 2007
Samaritan Pharma's SP-10 Hip on Hep C - (Hepatitis C Virus)
 

Breath of Life Product In-Licensed to Samaritan PharmaNEWS - January 22, 2007
Breath of Life Product In-Licensed to Samaritan Pharma
 

Samaritan Pharma In-Licenses Rights to Promote and Sell Six of Molteni's Prescription Drugs for Pain, Drug Addiction and Anesthesia in Greece and CyprusNEWS - January 16, 2007
Samaritan Pharma In-Licenses Rights to Promote and Sell Six of Molteni's Prescription Drugs for Pain, Drug Addiction and Anesthesia in Greece and Cyprus

2006

PR - December 7, 2006
FDA Grants IND to Samaritan's Novel Plaque Clearing Alzheimer's Drug and Requests Additional Information Be Provided Before Starting Its Proposed Phase I Trial

PR - December 5, 2006
Patent Application Published for SP-04

PR -November 30, 2006
Samaritan's Collaborating Scientist to Become McGill's New Research Star

NEWS - November 29, 2006 - Las Vegas Review Journal
Company to start human trials on Alzheimer's drug Medication has proven effective in clearing plaque in brains of animals

NEWS - November 16, 2006
2006 North American Frost & Sullivan Award for Technology Innovation Award Recipient: Samaritan Pharmaceuticals, Inc.

Partnering
Opportunities

Samaritan Email
News Alert Signup:
Name:
Email:
Address:
Address:
City:
State:
Zip:
Phone: